{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:53:08Z","timestamp":1776271988525,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Schizophrenia Research Institute"},{"name":"National Health and Medical Research Council of Australia, Schizophrenia Research Institute"},{"DOI":"10.13039\/100000027","name":"National Institute of Alcohol Abuse and Alcoholism","doi-asserted-by":"crossref","award":["R24AA012725"],"award-info":[{"award-number":["R24AA012725"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["635231"],"award-info":[{"award-number":["635231"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.schres.2015.05.001","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T03:56:14Z","timestamp":1433476574000},"page":"212-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia"],"prefix":"10.1016","volume":"166","author":[{"given":"Natalie","family":"Matosin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Fernandez-Enright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy S.","family":"Lum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly A.","family":"Newell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.schres.2015.05.001_bb0005","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/npp.2009.30","article-title":"mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning","volume":"34","author":"Ayala","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.schres.2015.05.001_bb0010","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/hipo.1065","article-title":"GluR5, 6, 7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives","volume":"11","author":"Benes","year":"2001","journal-title":"Hippocampus"},{"issue":"6622","key":"10.1016\/j.schres.2015.05.001_bb0015","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/386284a0","article-title":"Homer: a protein that selectively binds metabotropic glutamate receptors","volume":"386","author":"Brakeman","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.schres.2015.05.001_bb0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0006-8993(94)01384-T","article-title":"Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers","volume":"674","author":"Breese","year":"1995","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.schres.2015.05.001_bb0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0169-328X(94)00247-C","article-title":"Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluRl and GluR2 in medial temporal lobe neurons in schizophrenia","volume":"29","author":"Eastwood","year":"1995","journal-title":"Mol. Brain Res."},{"issue":"6","key":"10.1016\/j.schres.2015.05.001_bb0025","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0006-3223(96)00220-X","article-title":"Immunoautoradiographic evidence for a loss of \u03b1-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia","volume":"41","author":"Eastwood","year":"1997","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2015.05.001_bb0035","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/brain\/awr155","article-title":"Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition","volume":"134","author":"Engmann","year":"2011","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.schres.2015.05.001_bb0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/bies.20518","article-title":"The trick of the tail: protein\u2013protein interactions of metabotropic glutamate receptors","volume":"29","author":"Enz","year":"2007","journal-title":"Bioessays"},{"issue":"1","key":"10.1016\/j.schres.2015.05.001_bb0045","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1038\/tp.2013.121","article-title":"Novel implications of Lingo-1 and its signaling partners in schizophrenia","volume":"4","author":"Fernandez-Enright","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2015.05.001_bb0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jnr.21491","article-title":"Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain","volume":"86","author":"Han","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.schres.2015.05.001_bb0055","series-title":"Cognitive Impairment in Schizophrenia: Characteristics, Assessment and Treatment","author":"Harvey","year":"2013"},{"key":"10.1016\/j.schres.2015.05.001_bb0060","article-title":"The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies","author":"Hu","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.schres.2015.05.001_bb0065","doi-asserted-by":"crossref","DOI":"10.1124\/mol.114.094763","article-title":"Location-dependent signaling of the group 1 metabotropic glutamate receptor, mGlu5","author":"Jong","year":"2014","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.schres.2015.05.001_bb0070","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1523\/JNEUROSCI.22-04-01280.2002","article-title":"Tamalin, a PDZ domain-containing protein, links a protein complex formation of group 1 metabotropic glutamate receptors and the guanine nucleotide exchange factor cytohesins","volume":"22","author":"Kitano","year":"2002","journal-title":"J. Neurosci."},{"issue":"17","key":"10.1016\/j.schres.2015.05.001_bb0075","doi-asserted-by":"crossref","first-page":"14762","DOI":"10.1074\/jbc.M300184200","article-title":"Tamalin is a scaffold protein that interacts with multiple neuronal proteins in distinct modes of protein\u2013protein association","volume":"278","author":"Kitano","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.schres.2015.05.001_bb0080","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1523\/JNEUROSCI.17-13-05196.1997","article-title":"Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP","volume":"17","author":"Lu","year":"1997","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.schres.2015.05.001_bb0085","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/cercor\/bhi047","article-title":"The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity","volume":"15","author":"Manahan-Vaughan","year":"2005","journal-title":"Cereb. Cortex"},{"issue":"3","key":"10.1016\/j.schres.2015.05.001_bb0095","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neubiorev.2012.12.005","article-title":"Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia","volume":"37","author":"Matosin","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1-3","key":"10.1016\/j.schres.2015.05.001_bb0090","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.schres.2013.01.018","article-title":"Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment","volume":"146","author":"Matosin","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2015.05.001_bb0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuropharm.2012.06.005","article-title":"Role of metabotropic glutamate receptors in persistent forms of hippocampal plasticity and learning","volume":"66","author":"Mukherjee","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1-2","key":"10.1016\/j.schres.2015.05.001_bb0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0169-328X(00)00222-9","article-title":"Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus","volume":"85","author":"Ohnuma","year":"2000","journal-title":"Mol. Brain Res."},{"issue":"13","key":"10.1016\/j.schres.2015.05.001_bb0115","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1523\/JNEUROSCI.3451-13.2014","article-title":"Intracellular mGluR5 can mediate synaptic plasticity in the hippocampus","volume":"34","author":"Purgert","year":"2014","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.schres.2015.05.001_bb0130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jpsychires.2010.06.004","article-title":"Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients","volume":"45","author":"Spellmann","year":"2011","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.schres.2015.05.001_bb0135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.conb.2006.05.002","article-title":"Homer proteins: implications for neuropsychiatric disorders","volume":"16","author":"Szumlinski","year":"2006","journal-title":"Curr. Opin. Neurobiol."},{"issue":"12","key":"10.1016\/j.schres.2015.05.001_bb0120","first-page":"1","article-title":"Characterization of the brain 26S proteasome and its interacting proteins","volume":"3","author":"Tai","year":"2010","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.schres.2015.05.001_bb0125","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamapsychiatry.2013.1195","article-title":"Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families","volume":"70","author":"Timms","year":"2013","journal-title":"JAMA Psychiatry Chic."},{"key":"10.1016\/j.schres.2015.05.001_bb9000","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/187221411794351851","article-title":"Pharmacoperones: A New Therapeutic Approach for Diseases Caused By Misfolded G Protein-Coupled Receptors","volume":"5","author":"Ulloa-Aguirre","year":"2011","journal-title":"Recent Pat. Endocr. Metab. Immune Drug Discov."},{"issue":"7","key":"10.1016\/j.schres.2015.05.001_bb0140","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s11064-010-0145-z","article-title":"Expression of the hippocampal NMDA receptor GluN1 subunit and its splicing isoforms in schizophrenia: postmortem study","volume":"35","author":"Vrajov\u00e1","year":"2010","journal-title":"Neurochem. Res."},{"issue":"5959","key":"10.1016\/j.schres.2015.05.001_bb0145","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1178496","article-title":"Norbin is an endogenous regulator of metabotropic glutamate receptor 5 signaling","volume":"326","author":"Wang","year":"2009","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.schres.2015.05.001_bb0150","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.euroneuro.2011.09.003","article-title":"Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels","volume":"22","author":"Weston-Green","year":"2012","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641500239X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641500239X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T05:37:47Z","timestamp":1566797867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099641500239X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":30,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S092099641500239X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2015.05.001","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2015.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}